Tisotumab Vedotin, Datopotamab Deruxtecan Among Products Awaiting EMA Verdict

 
• By Vibha Sharma

Antibody-drug conjugates for treating cancer and vaccines to protect against chikungunya and pneumococcal pneumonia are among several products being considered for marketing approval by the European Medicines Agency’s human medicines committee, the CHMP.

Two hands signalling thumbs up and thumbs down. The smooth hand on the left is making a thumbs up gesture while the hairy hand on the right is making a thumbs down gesture.
Several sponsors are due to learn if their products will get a thumbs up from the EMA • Source: Shutterstock

More from EU CHMP

More from Pink Sheet